New-Onset Atrial Fibrillation in Patients With Primary Aldosteronism Receiving Different Treatment Strategies: Systematic Review and Pooled Analysis of Three Studies
BackgroundPrimary aldosteronism (PA) is a common cause of secondary hypertension and associated with higher incidence of new-onset atrial fibrillation (NOAF). However, the effects of surgical or medical therapies on preventing NOAF in PA patents remain unclear. The aim of this meta-analysis study wa...
Main Authors: | Cheng-Hsuan Tsai, Ya-Li Chen, Chien-Ting Pan, Yen-Tin Lin, Po-Chin Lee, Yu-Wei Chiu, Che-Wei Liao, Zheng-Wei Chen, Chin-Chen Chang, Yi-Yao Chang, Chi-Sheng Hung, Yen-Hung Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-05-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2021.646933/full |
Similar Items
-
Improvement in quality of life and psychological symptoms after treatment for primary aldosteronism: Asian Cohort Study
by: Yen Kheng Tan, et al.
Published: (2021-07-01) -
Composite Cardiovascular Outcomes in Patients With Primary Aldosteronism Undergoing Medical Versus Surgical Treatment: A Meta-Analysis
by: Wei-Chieh Huang, et al.
Published: (2021-05-01) -
Aldosterone and the heart: still an unresolved issue?
by: Cristiana eCatena, et al.
Published: (2014-10-01) -
Managing resistant hypertension: focus on mineralocorticoid-receptor antagonists
by: Yugar-Toledo JC, et al.
Published: (2017-10-01) -
Molecular Mechanisms of Primary Aldosteronism
by: Sergei G. Tevosian, et al.
Published: (2019-12-01)